Expert Opinion. Using Pharmacogenetic Testing or Platelet Reactivity Testing to Tailor Antiplatelet Therapy: Are Asians different from Caucasians?

Expert Opinion. Using Pharmacogenetic Testing or Platelet Reactivity Testing to Tailor Antiplatelet Therapy: Are Asians different from Caucasians?

Eur Cardiology Review

Saved in:

書目詳細資料
主要作者:	Tan DSY
其他作者:	PHARMACY
格式:	Article
出版:	2020
在線閱讀:	https://scholarbank.nus.edu.sg/handle/10635/176988
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!
機構:	National University of Singapore

相似書籍

Using Pharmacogenetic Testing to Tailor Warfarin Therapy: The Singapore Experience and What the Future Holds
由: Chang, Grace Shu-wen, et al.
出版: (2021)

Comparative performance of pharmacogenetics-based warfarin dosing algorithms derived from Caucasian, Asian, and mixed races in Thai population
由: Supatat Chumnumwat, et al.
出版: (2018)

Comparative performance of pharmacogenetics-based warfarin dosing algorithms derived from Caucasian, Asian, and mixed races in Thai population
由: Supatat Chumnumwat, et al.
出版: (2018)

Comparative performance of pharmacogenetics-based warfarin dosing algorithms derived from Caucasian, Asian, and mixed races in Thai population
由: Supatat Chumnumwat, et al.
出版: (2019)

HEALTH ECONOMICS OF PHARMACOGENETIC TESTING
由: DONG DI
出版: (2015)

In vitro antiplatelet activity of lusianthridin in human platelets
由: Hla Nu Swe
出版: (2019)

Differences in outcome and toxicity between Asian and caucasian patients with lung cancer treated with systemic therapy
由: Soo, R.A., et al.
出版: (2014)

Expert consensus on Dual Antiplatelet Therapy (DAPT) for acute coronary syndrome in Thailand: Review article
由: R. Kunjara-Na-Ayudhya, et al.
出版: (2020)

Pharmacogenetics of Warfarin Should we test?
由: Pantep Angchaisuksiri, et al.
出版: (2022)

Racial difference in the prevalence of epiretinal membrane between Caucasians and Asians
由: Kawasaki, R., et al.
出版: (2011)

Genetic differences between Asian and Caucasian chronic lymphocytic leukemia
由: Kawamata, N., et al.
出版: (2016)

Mechanism of antiplatelet aggregation of angelica dahurica extract in human platelets
由: Vivan Prompradith
出版: (2015)

Do we need perioperative pharmacogenetic testing?
由: Sirirat Rattana-Arpa, et al.
出版: (2019)

Optimal use of perampanel in asian patients with epilepsy: Expert opinion
由: Yotin Chinvarun, et al.
出版: (2022)

Differences between Asians & Caucasians in chemotherapeutic related outcomes in patients with colorectal cancer
由: CHUA HSIANG LIM, DARREN
出版: (2010)

Pharmacogenetic study of CYP2C19 variation and clopidogrel dose adjustment according to platelet reactivity monitoring in atherothromboticrisk patients in Thailand
由: Ramaimon Tunthong, et al.
出版: (2018)

Clinical trial: Effects of adefovir dipivoxil therapy in Asian and Caucasian patients with chronic hepatitis B
由: Lim, S.G., et al.
出版: (2011)

Single or dual antiplatelet therapy after PCI
由: Yosuke Miyazaki, et al.
出版: (2018)

Single or dual antiplatelet therapy after PCI
由: Yosuke Miyazaki, et al.
出版: (2018)

Single or dual antiplatelet therapy after PCI
由: Miyazaki Y., et al.
出版: (2017)

Immunofluorescent Staining of Platelet Suspensions and Detection of Antiplatelet Antibody in Patients with Idiopathic Thrombocytopenic Purpura
由: Somnate Boonpucknavig, et al.
出版: (2018)

The population attributable fraction as a measure of the impact of warfarin pharmacogenetic testing
由: Chan, S.L., et al.
出版: (2014)

Letter regarding Article, "Clinical outcomes and sustainability of using CYP2C19 genotype-guided antiplatelet therapy after percutaneous coronary intervention"
由: Aw JWX, et al.
出版: (2020)

Systemic therapies for pancreatic cancer - the role of pharmacogenetics
由: Soo, R.A., et al.
出版: (2014)

Antiplatelet therapy in aneurysmal subarachnoid hemorrhage: an updated meta-analysis
由: Lee, Keng Siang, et al.
出版: (2023)

Review of postoperative bleeding risk in dental patients on antiplatelet therapy
由: Napeñas, J.J., et al.
出版: (2013)

Opinion: Tailoring the lighting environment for a healthier ocular growth
由: Najjar, Raymond P
出版: (2022)

Pharmacogenetics of Doxorubicin in Asian Breast Cancer Patients
由: SUMAN LAL CHIRAMMAL SUGUNAN
出版: (2011)

Pharmacogenetics of Tamoxifen in Asian Breast Cancer Patients
由: LIM SIOK LIU
出版: (2013)

Platelet function tests in thalassemic children.
由: P. Isarangkura, et al.
出版: (2018)

Economic analysis of pharmacogenetics testing for human leukocyte antigen-based adverse drug reactions
由: Yuliwulandari R.
出版: (2023)

Recent progress and clinical importance on pharmacogenetics in cancer therapy
由: Soh, T.I.P., et al.
出版: (2014)

Comparison of the pharmacokinetics and pharmacodynamics of S-1 between Caucasian and East Asian patients
由: Chuah, B., et al.
出版: (2014)

Comparison of rivaroxaban concentrations between Asians and Caucasians and their correlation with PT/INR
由: Ng HOT, et al.
出版: (2020)

Geographic and ethnic differences in childhood leukaemia and lymphoma survival: Comparisons of Philippine residents, Asian Americans and Caucasians in the United States
由: Redaniel, M.T., et al.
出版: (2016)

Expert opinion on vaccination of travelers against Japanese encephalitis
由: Burchard, G.D., et al.
出版: (2011)

Clopidogrel pharmacogenetics of east, south and other Asian populations
由: Chan, M.Y.
出版: (2016)

Evaluation of a pharmacogenetic test in thailand for abacavir hypersensitivity screening in human immunodeficiency virus infection
由: Chonlaphat Sukasem, et al.
出版: (2018)

Willingness-to-pay and preferences for warfarin pharmacogenetic testing in Chinese warfarin patients and the Chinese general public
由: Chan, S.L., et al.
出版: (2014)

Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies
由: Mohitosh Biswas, et al.
出版: (2022)